About GLO Pharma
GLO Pharma is a private company based in Carlsbad, California, incorporated in 2018 in Delaware. It has reported $60,356,000 raised in three offerings on Form D since November 2020. Its chief executive is Vimla Black-Gupta.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 30, 2021 | Sep 14, 2021amended Sep 11, 2023 | $53,000,000fully sold | 189 | $280K | EquityRule 506(b) | Form D/A ↗4 earlier filings |
| Nov 13, 2020 | Nov 25, 2020 | $6,845,000fully sold | 20 | $342K | EquityRule 506(b) | Form D ↗ |
| Nov 12, 2020 | Nov 25, 2020 | $511,000fully sold | 22 | $23,227 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $60,356,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on GLO Pharma's Form D filed Sep 11, 2023.
DQ
Dayna Quanbeck
Director
NQ
Nicole Quinn
Director
MB
Marla Beck
Director
MC
Maureen Case
Director
FS
Fabian Seelbach
Director
DW
Douglas Wall
Director
LO
Lauren Otsuki
Executive officer and director
Also a director at Evida Biosciences and a president and chief executive officer, director at SRT Therapeutics.
VG
Vimla Black-Gupta
President and Chief Executive Officer, director
Earlier filings also listed Todd Jackson (director, last listed Nov 2020), Scott Glenn (ceo, president, treasurer and secretary, director, last listed Nov 2020) and Jana Messersmith (director, last listed Nov 2020).